Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 · kind B2 · utility
11Cited by
5References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2011 |
| Grant date | Aug 19, 2014 |
| Priority date | — |
| Expiry date | Nov 2, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The potency of a topical corticosteroid in a pharmaceutical formulation is maintained even when the concentration of the corticosteroid is substantially reduced by providing the corticosteroid in a formulation containing a liquid oil component that includes a dicarboxylic acid ester and/or a monocarboxylic acid ester.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.